(TBPH) Theravance Biopharma complete technical analysis [charts+indicators] | Buy/Sell Theravance Biopharma | (TBPH) share price targets
Complete technical analysis of Theravance Biopharma (TBPH) by charts plus indicators, forecast predictions and share price targets for Theravance Biopharma (TBPH)
Theravance Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-10 View latest technical analysis
10 day averaged volume of Theravance Biopharma is 223419
Date | Daily Closing Price | Open | High | Low | Volume |
10 Tue Sep 2024 | 8.13 | 8.02 | 8.19 | 8.00 | 1.331 times |
09 Mon Sep 2024 | 8.00 | 8.03 | 8.15 | 7.99 | 1.277 times |
06 Fri Sep 2024 | 8.01 | 8.18 | 8.20 | 8.01 | 0.853 times |
05 Thu Sep 2024 | 8.17 | 8.09 | 8.18 | 8.05 | 0.786 times |
04 Wed Sep 2024 | 8.04 | 7.98 | 8.13 | 7.94 | 0.867 times |
03 Tue Sep 2024 | 8.00 | 8.18 | 8.24 | 7.98 | 1.108 times |
30 Fri Aug 2024 | 8.25 | 8.19 | 8.29 | 8.09 | 1.061 times |
30 Fri Aug 2024 | 8.25 | 8.19 | 8.29 | 8.09 | 1.061 times |
29 Thu Aug 2024 | 8.21 | 8.15 | 8.36 | 8.15 | 0.705 times |
28 Wed Aug 2024 | 8.16 | 8.33 | 8.43 | 8.16 | 0.709 times |
My analysis of stock is bearish for shortterm, and stock might move down till 8 or till 7.9. Use a stoploss of 8.15 and if the stock hits stoploss, then it can shoot up till 8.26
Share price targets for Theravance Biopharma (TBPH)
Target Type | Value |
Downside Target | 7.44 |
Downside Target | 7.92 |
Upside Target | 8.24 |
Upside Target | 8.28 |
Upside Target | 8.29 |
Upside Target | 8.40 |
Upside Target | 8.43 |
Upside Target | 9.01 |
Upside Target | 10.22 |
Upside Target | 10.37 |
Upside Target | 10.42 |
Intraday share price targets for Theravance Biopharma (TBPH)
Target Type | Value |
Downside Intraday Target | 8.02 |
Downside Intraday Target | 7.9 |
Upside Intraday Target | 8.22 |
Upside Intraday Target | 8.3 |
Downside Intraday Target | 8.1 |
Weekly technical analysis of Theravance Biopharma (TBPH)
Date | Weekly Closing Price | Open | High | Low | Volume |
10 Tue Sep 2024 | 8.13 | 8.03 | 8.19 | 7.99 | 0.722 times |
06 Fri Sep 2024 | 8.01 | 8.18 | 8.24 | 7.94 | 3.405 times |
30 Fri Aug 2024 | 8.25 | 8.19 | 8.29 | 8.09 | 0.223 times |
30 Fri Aug 2024 | 8.25 | 8.10 | 8.43 | 8.04 | 0.862 times |
23 Fri Aug 2024 | 8.09 | 8.16 | 8.40 | 7.92 | 0.882 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Theravance Biopharma (TBPH)
Date | Monthly Closing Price | Open | High | Low | Volume |
10 Tue Sep 2024 | 8.13 | 8.18 | 8.24 | 7.94 | 0.122 times |
30 Fri Aug 2024 | 8.25 | 10.16 | 10.22 | 7.44 | 1.459 times |
31 Wed Jul 2024 | 10.11 | 8.46 | 10.42 | 8.19 | 1.048 times |
28 Fri Jun 2024 | 8.48 | 8.68 | 9.01 | 8.28 | 0.833 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Theravance Biopharma (TBPH)
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Theravance Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Theravance Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Theravance Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Theravance Biopharma in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Theravance Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.12 and Theravance Biopharma (TBPH) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Theravance Biopharma (TBPH) stock. Volume based technical analysis of Theravance Biopharma (TBPH) stock is negative.
Theravance Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Theravance Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Theravance Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Theravance Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Theravance Biopharma in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Theravance Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.12 and Theravance Biopharma (TBPH) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Theravance Biopharma (TBPH) stock. Volume based technical analysis of Theravance Biopharma (TBPH) stock is negative.
Theravance Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.